Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$342M |
| 2 |
Intercontinental Exchange
ICE
|
+$284M |
| 3 |
Deere & Co
DE
|
+$255M |
| 4 |
Blackrock
BLK
|
+$248M |
| 5 |
Newmont
NEM
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$638M |
| 2 |
Alibaba
BABA
|
+$454M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$367M |
| 4 |
Pfizer
PFE
|
+$356M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$353M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 11.43% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Fortune Brands Innovations
FBIN
$5.86B
| $107M | 0.04% |
1,456,021
+922,086
| +173% | +$67.3M |
|
|
AYX
452
DELISTED
Alteryx Inc
AYX
| $106M | 0.04% |
873,943
-61,334
| -7% | -$7.73M |
|
453
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $106M | 0.04% |
2,750,934
+393,015
| +17% | +$14.7M |
|
|
HZNP
454
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $106M | 0.04% |
1,447,083
-104,930
| -7% | -$7.8M |
|
|
VMW
455
DELISTED
VMware, Inc
VMW
| $105M | 0.04% |
749,354
-123,698
| -14% | -$17.7M |
|
456
Motorola Solutions
MSI
$72.1B
| $105M | 0.04% |
616,897
-31,104
| -5% | -$5.22M |
|
457
Schwab US Mid-Cap ETF
SCHM
$14.2B
| $104M | 0.04% |
4,588,125
-263,028
| -5% | -$5.49M |
|
458
Five Below
FIVE
$11.6B
| $104M | 0.04% |
595,482
+21,232
| +4% | +$3.14M |
|
459
Celanese
CE
$4.82B
| $104M | 0.04% |
798,559
+308,671
| +63% | +$38.4M |
|
460
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $103M | 0.04% |
1,674,893
-185,853
| -10% | -$11.5M |
|
461
Zoom
ZM
$27.1B
| $102M | 0.04% |
303,121
-46,821
| -13% | -$20.9M |
|
|
REGI
462
DELISTED
Renewable Energy Group, Inc.
REGI
| $102M | 0.04% |
1,440,297
+1,182,664
| +459% | +$72.3M |
|
463
Yum! Brands
YUM
$41.9B
| $101M | 0.04% |
930,542
+4,235
| +0.5% | +$432K |
|
464
Nordson
NDSN
$16.4B
| $101M | 0.04% |
501,995
+11,855
| +2% | +$2.38M |
|
465
Penumbra
PEN
$12.6B
| $101M | 0.04% |
575,344
+211,729
| +58% | +$46.4M |
|
466
Paychex
PAYX
$43.4B
| $101M | 0.04% |
1,075,318
-556,281
| -34% | -$49.4M |
|
|
IPHI
467
DELISTED
INPHI CORPORATION
IPHI
| $100M | 0.04% |
625,261
+44,022
| +8% | +$6.19M |
|
468
West Pharmaceutical
WST
$23.7B
| $100M | 0.04% |
353,416
+14,346
| +4% | +$4.03M |
|
469
SBA Communications
SBAC
$19.8B
| $100M | 0.04% |
354,814
-159,619
| -31% | -$46.9M |
|
470
Genpact
G
$6.22B
| $99.8M | 0.04% |
2,411,843
+390,915
| +19% | +$15.4M |
|
471
Zimmer Biomet
ZBH
$18.8B
| $99.6M | 0.04% |
666,042
+3,835
| +0.6% | +$542K |
|
472
Zoetis
ZTS
$32.7B
| $99.6M | 0.04% |
601,835
-102,379
| -15% | -$16.6M |
|
473
Copart
CPRT
$28.5B
| $99.3M | 0.04% |
3,122,664
+439,672
| +16% | +$12.8M |
|
474
Howmet Aerospace
HWM
$109B
| $99.2M | 0.04% |
3,488,436
+3,014,484
| +636% | +$67M |
|
475
Quest Diagnostics
DGX
$26B
| $99.1M | 0.04% |
832,037
-1,874,206
| -69% | -$228M |
|
Similar funds
Ameriprise's Q4 2020 Portfolio in Review
As of Q4 2020, Ameriprise held 3,918 positions worth $282B, up 15% from $246B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q4 2020 filing shows 198 new, 1,664 increased, 1,807 reduced and 165 closed positions. Its largest new stake was Array Technologies: 1,865,836 shares worth $80.5M. The largest sale was Apple, an estimated $638M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2020 buy was Array Technologies: 1,865,836 shares worth $80.5M.
- Ameriprise added most to Morgan Stanley in Q4 2020, an estimated $342M increase.
- Ameriprise's biggest Q4 2020 reduction was Apple, cutting an estimated $638M.
- Ameriprise fully exited Immunomedics Inc in Q4 2020, selling an estimated $149M.
- Ameriprise's ten largest holdings make up 16% of its $282B portfolio in Q4 2020.
- Ameriprise opened 198 new positions and closed 165 in Q4 2020.
- Ameriprise's portfolio value rose 15% quarter-over-quarter to $282B.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.